Based on the MV loaded with suicide gene super-cytosine deaminase (SCD), MV-SCD has a vigorous oncolytic activity on HCC in vitro and in vivo, which indicated that suicide gene therapy based on MV is a potential new treatment scheme for HCC to overcome the drug resistance of conventional treatment [40]. This evidence concerns the gene SCD and hepatocellular carcinoma.